These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 26298521

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Homma K, Yoshizawa J, Shiina Y, Ozawa H, Igarashi M, Matsuoka T, Sasaki J, Yoshizawa M, Homma Y.
    Drugs R D; 2017 Sep; 17(3):397-402. PubMed ID: 28577292
    [Abstract] [Full Text] [Related]

  • 26. The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.
    Fujii Y, Abe M, Higuchi T, Mizuno M, Suzuki H, Matsumoto S, Ito M, Maruyama N, Okada K, Soma M.
    Expert Opin Pharmacother; 2013 Feb; 14(3):259-67. PubMed ID: 23289982
    [Abstract] [Full Text] [Related]

  • 27. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
    Abe M, Okada K.
    Contrib Nephrol; 2015 Feb; 185():98-115. PubMed ID: 26023019
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K, Shibata R, Nakayama H, Yamada K, Okuda S, Koga M.
    J Diabetes Complications; 2015 Feb; 29(7):913-7. PubMed ID: 26164356
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis.
    Park SH, Nam JY, Han E, Lee YH, Lee BW, Kim BS, Cha BS, Kim CS, Kang ES.
    Medicine (Baltimore); 2016 Aug; 95(32):e4543. PubMed ID: 27512877
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
    Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Iijima H, Watanabe Y, Gouda M.
    Diabetes Obes Metab; 2017 Jun; 19(6):874-882. PubMed ID: 28177187
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis.
    Hayashi A, Takano K, Masaki T, Yoshino S, Ogawa A, Shichiri M.
    J Diabetes Complications; 2016 Jun; 30(8):1494-1499. PubMed ID: 27614726
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis.
    Yajima T, Yajima K, Hayashi M, Takahashi H, Yasuda K.
    Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154
    [Abstract] [Full Text] [Related]

  • 37. Teneligliptin : expectations for its pleiotropic action.
    Morishita R, Nakagami H.
    Expert Opin Pharmacother; 2015 Feb; 16(3):417-26. PubMed ID: 25597385
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.
    Kutoh E, Wada A, Terayama S.
    Clin Drug Investig; 2016 Oct; 36(10):809-18. PubMed ID: 27352309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.